Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors-Reference-Cited by-同舟云学术

Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors

Published:2023-09-18 Issue:10 Volume:20 Page:4826-4847
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Wijfjes Zacharias¹²^ORCID,van Dalen Floris J.¹²,Le Gall Camille M.¹²^ORCID,Verdoes Martijn¹²^ORCID

Affiliation:

1. Chemical Immunology group, Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands

2. Institute for Chemical Immunology, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands

Funder

H2020 European Research Council

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00330

Reference261 articles.

1. Global Eradication of Smallpox

2. Rinderpest Eradication: Appropriate Technology and Social Innovations

3. Toll-like receptor control of the adaptive immune responses

4. Dendritic cells in a mature age

5. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity;International Immunopharmacology;2024-12

2. The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects;Biomedicines;2024-09-02